Jae-Hyung Park

12PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsPredictive and prognostic markersPeripheral nervous systemNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
Evaluation of the Anti-Cancer Effects of KMU-11342 in In Vitro and Ex Vivo Models of Colorectal Cancer.

|May 04, 2026
APOC3 Promotes DGAT2-Dependent Triglyceride Accumulation in Hepatocytes During Early Metabolic Dysfunction.

|Feb 27, 2026
Plasma EV miR-186-5p as an Early Biomarker and Regulator of IFN-α-Mediated Oxidative and β-Cell Dysfunction in Prediabetes.

Jae-Hyung Park, Thi Nhi Nguyen, Hye Min Shim

|Feb 10, 2026
Sphingolipid metabolism-related genes B4GALNT1 and CERS4 as prognostic biomarkers in lung adenocarcinoma.

Jieun Jeon, Junho Kang, Jae-Hyung Park

|Jan 28, 2026
Plasma Mucin-1 as a Potential Biomarker for Diabetic Peripheral Neuropathy in Type 2 Diabetes.

Jae-Hyung Park, Thi Nhi Nguyen, Hye Min Shim

|Nov 13, 2025
Peptide YY in Type 2 Diabetes: A Complementary Gut Hormone with Therapeutic Potential Beyond GLP-1.

Nhi Thi Nguyen, Jae-Hyung Park

Pageof 2

Frequent Collaborators

4 joint publications

Jaechan Leem

4 joint publications

Eun Young Ha

3 joint publications

Gyeong Im Yu

3 joint publications

Hochan Cho